MustGrow Biologics Corp.
MGROF
$0.6588
-$0.0576-8.04%
| Weiss Ratings | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.60 | |||
| Price History | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -17.04% | |||
| 30-Day Total Return | -33.45% | |||
| 60-Day Total Return | -40.65% | |||
| 90-Day Total Return | -46.87% | |||
| Year to Date Total Return | -26.91% | |||
| 1-Year Total Return | -18.96% | |||
| 2-Year Total Return | -68.33% | |||
| 3-Year Total Return | -78.95% | |||
| 5-Year Total Return | 163.52% | |||
| 52-Week High % Change | -61.94% | |||
| 52-Week Low % Change | 62.48% | |||
| Price | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.73 | |||
| 52-Week Low Price | $0.41 | |||
| 52-Week Low Price (Date) | Aug 06, 2024 | |||
| 52-Week High Price (Date) | Oct 28, 2024 | |||
| Valuation | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 34.20M | |||
| Enterprise Value | 32.03M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -96.99% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 9.28 | |||
| Price/Book (Q) | 13.64 | |||
| Enterprise Value/Revenue (TTM) | 8.73 | |||
| Price | $0.66 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | 239.36 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 51.64M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 306 668 2652 | |||
| Address | 1005 – 201 1st Avenue South Saskatoon, SK S7K 1J5 | |||
| Website | mustgrow.ca | |||
| Country | Canada | |||
| Year Founded | 2014 | |||
| Profitability | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 3.64% | |||
| Profit Margin | -4.90% | |||
| Management Effectiveness | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.61% | |||
| Return on Equity | -- | |||
| Income Statement | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.67M | |||
| Total Revenue (TTM) | 3.67M | |||
| Revenue Per Share | $0.07 | |||
| Gross Profit (TTM) | 3.48M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | 133.80K | |||
| Net Income (TTM) | -179.80K | |||
| Net Income Avl. to Common (TTM) | -179.80K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 11.12% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 14.03% | |||
| Balance Sheet | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.64M | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 3.19M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.49M | |||
| Current Ratio (Q) | 5.377 | |||
| Book Value Per Share (Q) | $0.05 | |||
| Total Assets (Q) | 3.19M | |||
| Total Current Liabilities (Q) | 593.70K | |||
| Total Debt (Q) | 383.40K | |||
| Total Liabilities (Q) | 698.00K | |||
| Total Common Equity (Q) | 2.49M | |||
| Cash Flow | MGROF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -176.40K | |||
| Net Change in Cash (TTM) | -435.70K | |||
| Levered Free Cash Flow (TTM) | 330.70K | |||
| Cash from Operations (TTM) | -259.40K | |||
